INTERNATIONAL PATENT: KOLM THERAPEUTICS INC. FILES APPLICATION FOR "HETEROBIFUNCTIONAL CONDITIONAL INHIBITORS"

GENEVA, April 21 -- KOLM THERAPEUTICS INC. (4 Research Dr.Woodbridge, Connecticut 06525) filed a patent application (PCT/US2024/051113) for "HETEROBIFUNCTIONAL CONDITIONAL INHIBITORS" on Oct 11, 2024. With publication no. WO/2025/081091, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NEKLESA, Taavi (4 Research Dr.Woodbridge, Connecticut 06525), VIGIL, Dominico (4 Research Dr.Woodbridge, Connecticut 06525), LEFKER, Bruce A. (4 Research Dr.Woodbridge, Connecticut 06525), ROBINSON, Ralph P. (4 Research Dr.Woodbridge, Connec...